Katayoun Zomorodi

Title: The Innovative Contributions of Katayoun Zomorodi

Introduction

Katayoun Zomorodi is a notable inventor based in San Jose, CA, who has made significant contributions to the field of pharmacology. With a total of 18 patents to her name, she has demonstrated an exceptional ability to innovate in the healthcare sector, particularly in therapies that enhance patient care.

Latest Patents

Among her recent patents, Zomorodi has developed methods for providing solriamfetol therapy to subjects with impaired renal function. This invention addresses the adverse effects associated with solriamfetol, specifically [R]-2-amino-3-phenylpropylcarbamate therapy. Her work includes an optimized dose escalation scheme for subjects with moderate renal impairment, thereby improving their tolerance to the therapy. Moreover, the patent outlines adjusted dosing guidelines for safe usage in patients with severe renal impairment, highlighting her commitment to improving therapeutic outcomes for vulnerable populations.

Career Highlights

Throughout her career, Zomorodi has worked with prominent companies in the pharmaceutical industry, including Axsome Malta Ltd. and Jazz Pharmaceuticals Ireland Limited. Her roles in these organizations have contributed to her deep understanding of drug development and patient safety.

Collaborations

Zomorodi has collaborated with esteemed colleagues, including Lawrence Patrick Carter and Yuan Lu, to push the boundaries of innovation in therapeutic strategies. These collaborations reflect a synergy of expertise that enables the development of more effective treatment approaches.

Conclusion

Katayoun Zomorodi stands out as an influential inventor whose work has the potential to significantly enhance the safety and efficacy of drug therapies for patients with renal impairments. Her dedication to innovation in pharmacology not only exemplifies her skills but also contributes positively to the medical community and patient care.